STAT3 and hepatocellular carcinoma: In addition to a previous study referring to IL-6/STAT3 signaling in the activation of PDL1 expression in lung cancer [29] and M2-type macrophages in hepatocellular carcinoma [30], here, we provide indirect and direct evidence for such a function of IL-6 in gastric cancer.